Released : 05/01/2018 09:49
RNS Number : 0928B
Evgen Pharma PLC
05 January 2018
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||
1. Identity of the issuer or the underlying issuer | Evgen Pharma plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
An event changing the breakdown of voting rights | ||||
Other (please specify): | change in percentage of voting rights arising upon a new issue of shares by the issuer | ü | ||
3. Full name of person(s) subject to the | Enterprise Ventures Limited | |||
4. Full name of shareholder(s) (if different from 3.): | South Yorkshire Investment Fund Limited | |||
5. Date of the transaction and date on | Total Voting Rights announcement of the issuer dated 2 January 2018 | |||
6. Date on which issuer notified: | 4 January 2017 | |||
7. Threshold(s) that is/are crossed or | 5% | |||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares | ||||||||||||||||
Class/type of
if possible using |
Situation previous | Resulting situation after the triggering transaction | ||||||||||||||
Number |
Number |
Number |
Number of voting | % of voting rights | ||||||||||||
Direct | Direct | Indirect | Direct | Indirect | ||||||||||||
GB00BSVYN304 | 3,772,949 | 3,772,949 | 3,772,949 | 3,772,949 | Nil | 4.04 | Nil | |||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting | ||||||||||||
None | ||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financial | Exercise price | Expiration date |
Exercise/ | Number of voting rights instrument refers to | % of voting rights | |||||||||||
None | Nominal | Delta | ||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
3,772,949 | 4.04% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the | ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will cease | ||
12. Date on which proxy holder will cease to hold | ||
13. Additional information: | ||
14. Contact name: | Enterprise Ventures Limited | |
15. Contact telephone number: | 01772 270 570 | |
This information is provided by RNS
The company news service from the London Stock Exchange
ENDHOLGCGDBRSGBGIU
Evgen Pharma plc published this content on 05 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 January 2018 09:59:03 UTC.
Original documenthttp://otp.investis.com/clients/uk/evgen_pharma/rns/regulatory-story.aspx?cid=1240&newsid=963557
Public permalinkhttp://www.publicnow.com/view/87DCCDCFC9901210EB2D4515CE33A04FD40F252C